TORONTO -- Researchers at McMaster University in Hamilton, Ont., have been approved to begin human trials on two Canadian-made COVID-19 vaccines that are delivered by inhaled aerosol to target the lungs and upper airways.
“Besides its multi-antigenic vaccine design, our vaccine strategy differs from all of the current first-generation COVID-19 vaccines in the route of delivery. Ours gets delivered into the lung via inhaled aerosol to induce respiratory mucosal immunity, known to provide best protection against respiratory pathogens,” Xing said in the release.
“The original vaccines that have been developed have really got us out of a tricky situation 12 months ago, but now I think it’s very important to take time to refine our approaches and to look at some of these new strategies where the [inhaled] vaccinations may be more effective against variants as they evolve and perhaps overall more effective at protecting against infection,” Smaill said.
“I think we want to get ourselves out of that cycle with COVID-19 by designing vaccines that allow us to finally get one step ahead of the virus and protect against variants that may not have even emerged yet,” he said.
97% covid cases are mild for any variants Squirting sh1t monthly into your arm ear nose or up your as$ may feel good but isn't going to change 97% get mild symptoms doing nothing
Good news - many people are afraid of needles and don't get vaccinated because of it - the more treatment options, the better (I'm fully vaccinated by needle but don't like needles in general)